Cargando…

Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages

Tuberculosis (TB) is one of the top 10 leading causes of death worldwide. The recombinant BCG strain expressing the genetically detoxified A subunit of the thermolabile toxin from Escherichia coli (LTAK63) adjuvant (rBCG-LTAK63) has previously been shown to confer superior protection and immunogenic...

Descripción completa

Detalles Bibliográficos
Autores principales:	dos Santos, Carina C., Walburg, Kimberley V., van Veen, Suzanne, Wilson, Louis G., Trufen, Carlos E. M., Nascimento, Ivan P., Ottenhoff, Tom H. M., Leite, Luciana C. C., Haks, Mariëlle C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227035/ https://www.ncbi.nlm.nih.gov/pubmed/35746439 http://dx.doi.org/10.3390/vaccines10060831

Ejemplares similares

Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis
por: Nascimento, Ivan P., et al.
Publicado: (2017)

Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria
por: Carvalho Dos Santos, Carina, et al.
Publicado: (2019)

Recombinant BCG expressing the LTAK63 adjuvant improves a short-term chemotherapy schedule in the control of tuberculosis in mice
por: Trentini, Monalisa Martins, et al.
Publicado: (2022)

CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tuberculosis Vaccine Candidate
por: Moraes, Luana, et al.
Publicado: (2022)

Recombinant BCG expressing the LTAK63 adjuvant increased memory T cells and induced long-lasting protection against Mycobacterium tuberculosis challenge in mice
por: Marques-Neto, Lázaro Moreira, et al.
Publicado: (2023)

Development of Human Cell-Based In Vitro Infection Models to Determine the Intracellular Survival of Mycobacterium avium
por: Kilinç, Gül, et al.
Publicado: (2022)

Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances in vitro and in vivo Anti-mycobacterial Activity in Human Macrophages and in Zebrafish
por: Moreira, Jôsimar D., et al.
Publicado: (2020)

Bioorthogonal Correlative Light-Electron Microscopy of Mycobacterium tuberculosis in Macrophages Reveals the Effect of Antituberculosis Drugs on Subcellular Bacterial Distribution
por: Bakkum, Thomas, et al.
Publicado: (2020)

A Bivalent Recombinant Mycobacterium bovis BCG Expressing the S1 Subunit of the Pertussis Toxin Induces a Polyfunctional CD4(+) T Cell Immune Response
por: Kanno, Alex I., et al.
Publicado: (2019)

Host‐directed therapy to combat mycobacterial infections
por: Kilinç, Gül, et al.
Publicado: (2021)

In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment
por: Rodriguez, Dunia, et al.
Publicado: (2019)

Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model
por: Chade, Daher C, et al.
Publicado: (2008)

New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters
por: Kanno, Alex I., et al.
Publicado: (2016)

Recombinant BCG Expressing the Subunit 1 of Pertussis Toxin Induces Innate Immune Memory and Confers Protection against Non-Related Pathogens
por: Kanno, Alex I., et al.
Publicado: (2022)

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections
por: Heemskerk, M. T., et al.
Publicado: (2021)

Characterisation of alternative expression vectors for recombinant Bacillus Calmette-Guérin as live bacterial delivery systems
por: Nascimento, Larissa V, et al.
Publicado: (2020)

Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of Salmonella enterica Serovar Typhimurium Infection in Human Macrophages
por: van Doorn, Cassandra L. R., et al.
Publicado: (2021)

Stratification of COVID-19 patients based on quantitative immune-related gene expression in whole blood
por: Persson, Josefine, et al.
Publicado: (2022)

100 Years of BCG Immunization: Past, Present, and Future
por: Tagliabue, Aldo, et al.
Publicado: (2022)

Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis
por: Boland, Ralf, et al.
Publicado: (2022)

Single-cell analysis reveals chemokine-mediated differential regulation of monocyte mechanics
por: Evers, Tom M.J., et al.
Publicado: (2021)

Human CD8(+) T-cells Recognizing Peptides from Mycobacterium tuberculosis (Mtb) Presented by HLA-E Have an Unorthodox Th2-like, Multifunctional, Mtb Inhibitory Phenotype and Represent a Novel Human T-cell Subset
por: van Meijgaarden, Krista E., et al.
Publicado: (2015)

Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults
por: Weinberger, Birgit, et al.
Publicado: (2018)

Early pneumococcal clearance in mice induced by systemic immunization with recombinant BCG PspA-PdT prime and protein boost correlates with cellular and humoral immune response in bronchoalveolar fluids (BALF)
por: Goulart, Cibelly, et al.
Publicado: (2019)

Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages
por: van Doorn, Cassandra L. R., et al.
Publicado: (2021)

Genome sequences of BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c
por: D’Auria, Giuseppe, et al.
Publicado: (2023)

Nonclinical Development of BCG Replacement Vaccine Candidates
por: Velmurugan, Kamalakannan, et al.
Publicado: (2013)

Analyzing the impact of Mycobacterium tuberculosis infection on primary human macrophages by combined exploratory and targeted metabolomics
por: Vrieling, Frank, et al.
Publicado: (2020)

Recombinant BCG to Enhance Its Immunomodulatory Activities
por: Kowalewicz-Kulbat, Magdalena, et al.
Publicado: (2022)

Recombinant HBHA Boosting Effect on BCG-Induced Immunity against Mycobacterium tuberculosis Infection
por: Guerrero, G. G., et al.
Publicado: (2011)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
por: Gunasena, Manuja, et al.
Publicado: (2022)

Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory
por: da Costa, Adeliane Castro, et al.
Publicado: (2014)

Gene expression profiles classifying clinical stages of tuberculosis and monitoring treatment responses in Ethiopian HIV-negative and HIV-positive cohorts
por: Gebremicael, Gebremedhin, et al.
Publicado: (2019)

Recombinant vaccines and the development of new vaccine strategies
por: Nascimento, I.P., et al.
Publicado: (2012)

Combination of gene expression patterns in whole blood discriminate between tuberculosis infection states
por: Mihret, Adane, et al.
Publicado: (2014)

Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes
por: Sivakumaran, Dhanasekaran, et al.
Publicado: (2020)

Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials
por: Korbee, Cornelis J., et al.
Publicado: (2018)

Cold acclimation affects immune composition in skeletal muscle of healthy lean subjects
por: van der Lans, Anouk A J J, et al.
Publicado: (2015)

Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
por: de Queiroz, Nina Marí G.P., et al.
Publicado: (2020)

Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates
por: van der Heijden, E. M. D. L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fam2bfc461lii8pkihb62out3v